pharmaceutical industry Archives | American Conference Institute

Check out all of the highlights from the 20th Anniversary Drug and Med Program in our brand new photo album

by American Conference Institute - December 8, 2015

Check out the photos from the event below:

Doctors Call for Drug Advertising Ban in Position Reversal

by American Conference Institute - November 19, 2015

By Zachary Tracer, Published on Bloomberg Business on November 17th, 2015 Drug companies should stop advertising directly to consumers, a major U.S. doctors group said Tuesday, declaring that the ads often push patients to more expensive treatments and inflate demand for therapies.

Check Out This Testimonial From One of our Drug and Med Conference "Royals" on What Keeps Her Coming Back Each Year

by American Conference Institute - November 2, 2015

Joyce Edelman, Porter Wright Morris & Arthur LLP, has been attending the Drug and Medical Device Litigation Forum for several years and is one of the conference’s “royals” – loyal attendees. When asked why she has continued to attend the conference (coming up December 2nd-4th), Joyce responded saying, “Each year I look forward to attending ACI’s…

Ferring's Muted Fertility Drug Recall Falls Within FDA Rules

by American Conference Institute - October 16, 2015

Published on Law360 on October 15th, 2015. New York – Ferring Pharmaceuticals has recalled fertility medication Bravelle with so little fanfare that it is mostly fertility clinics and pharmacies that have informed patients seeking refills, but attorneys say the drugmaker is nonetheless well-positioned to ward off potential consumer suits because its approach meets recall guidelines…

Impossibility Preemption Is Possible In 510(k) Device Cases

by American Conference Institute - October 14, 2015

Published on Law360on October 9th, 2015 The implied impossibility preemption argument against design defect claims involving Section 510(k) medical devices has only rarely been made in any form and has yet to succeed in the 501(k) context. But James Beck at Reed Smith LLP firmly believes that the impossibility preemption argument is right and should…

Pennsylvania Jury Clears Johnson & Johnson Over Children's Motrin Claims

by American Conference Institute - September 30, 2015

By Matt Fair, Published on Law360 on September 29th, 2015. NEW YORK – A Pennsylvania federal jury cleared a Johnson & Johnson unit on Tuesday of claims that over-the-counter Children’s Motrin caused a 3-year-old girl to develop a horrific skin condition that ultimately rendered her blind. [ Read More ] Related Event Here are just some of the…

Weekly Industry News – Pharma

by American Conference Institute - October 7, 2013

To read the complete article click on the title. Medical-device tax repeal is an idea full of holes Posted on WP Opinions by Editorial Board F THE Capitol Hill impasse ever ends, it will probably be through a compromise under which House Republicans abandon their demands to delay or defundObamacare — in return for a concession Senate…

Join Our Mailing List